<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.5.57">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Resume – Iago Pinal-Fernandez</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./favicon.ico" rel="icon">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>

  <script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6"></script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<script type="text/javascript">
const typesetMath = (el) => {
  if (window.MathJax) {
    // MathJax Typeset
    window.MathJax.typeset([el]);
  } else if (window.katex) {
    // KaTeX Render
    var mathElements = el.getElementsByClassName("math");
    var macros = [];
    for (var i = 0; i < mathElements.length; i++) {
      var texText = mathElements[i].firstChild;
      if (mathElements[i].tagName == "SPAN") {
        window.katex.render(texText.data, mathElements[i], {
          displayMode: mathElements[i].classList.contains('display'),
          throwOnError: false,
          macros: macros,
          fleqn: false
        });
      }
    }
  }
}
window.Quarto = {
  typesetMath
};
</script>

<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">Iago Pinal-Fernandez</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" role="menu" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html"> 
<span class="menu-text">Home</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link active" href="./cv.html" aria-current="page"> 
<span class="menu-text">Resume</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./contact.html"> 
<span class="menu-text">Contact</span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
            <div class="quarto-navbar-tools">
  <a href="" class="quarto-color-scheme-toggle quarto-navigation-tool  px-1" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
</div>
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#education" id="toc-education" class="nav-link active" data-scroll-target="#education">EDUCATION</a></li>
  <li><a href="#licensure-and-board-certification" id="toc-licensure-and-board-certification" class="nav-link" data-scroll-target="#licensure-and-board-certification">LICENSURE AND BOARD CERTIFICATION</a></li>
  <li><a href="#professional-experience" id="toc-professional-experience" class="nav-link" data-scroll-target="#professional-experience">PROFESSIONAL EXPERIENCE</a></li>
  <li><a href="#teaching" id="toc-teaching" class="nav-link" data-scroll-target="#teaching">TEACHING</a></li>
  <li><a href="#publications" id="toc-publications" class="nav-link" data-scroll-target="#publications">PUBLICATIONS</a>
  <ul class="collapse">
  <li><a href="#original-research" id="toc-original-research" class="nav-link" data-scroll-target="#original-research">Original research</a></li>
  <li><a href="#review-articles" id="toc-review-articles" class="nav-link" data-scroll-target="#review-articles">Review articles</a></li>
  <li><a href="#case-reports" id="toc-case-reports" class="nav-link" data-scroll-target="#case-reports">Case reports</a></li>
  <li><a href="#editorials" id="toc-editorials" class="nav-link" data-scroll-target="#editorials">Editorials</a></li>
  <li><a href="#letters-correspondence" id="toc-letters-correspondence" class="nav-link" data-scroll-target="#letters-correspondence">Letters, correspondence</a></li>
  <li><a href="#book-chapters" id="toc-book-chapters" class="nav-link" data-scroll-target="#book-chapters">Book chapters</a></li>
  </ul></li>
  <li><a href="#oral-presentations" id="toc-oral-presentations" class="nav-link" data-scroll-target="#oral-presentations">ORAL PRESENTATIONS</a></li>
  <li><a href="#posters" id="toc-posters" class="nav-link" data-scroll-target="#posters">POSTERS</a></li>
  <li><a href="#conferences-and-courses" id="toc-conferences-and-courses" class="nav-link" data-scroll-target="#conferences-and-courses">CONFERENCES AND COURSES</a></li>
  <li><a href="#scholarships-grants-and-awards" id="toc-scholarships-grants-and-awards" class="nav-link" data-scroll-target="#scholarships-grants-and-awards">SCHOLARSHIPS, GRANTS, AND AWARDS:</a></li>
  <li><a href="#research-protocols" id="toc-research-protocols" class="nav-link" data-scroll-target="#research-protocols">RESEARCH PROTOCOLS:</a></li>
  <li><a href="#peer-review-activities" id="toc-peer-review-activities" class="nav-link" data-scroll-target="#peer-review-activities">PEER-REVIEW ACTIVITIES:</a></li>
  <li><a href="#collaboration-with-pharmaceutical-companies" id="toc-collaboration-with-pharmaceutical-companies" class="nav-link" data-scroll-target="#collaboration-with-pharmaceutical-companies">COLLABORATION WITH PHARMACEUTICAL COMPANIES:</a></li>
  <li><a href="#membership-in-scientific-associations" id="toc-membership-in-scientific-associations" class="nav-link" data-scroll-target="#membership-in-scientific-associations">MEMBERSHIP IN SCIENTIFIC ASSOCIATIONS:</a></li>
  <li><a href="#languages" id="toc-languages" class="nav-link" data-scroll-target="#languages">LANGUAGES:</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Resume</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<section id="education" class="level1">
<h1>EDUCATION</h1>
<ul>
<li><p>Medicine Degree<br>
University of Santiago de Compostela, Spain<br>
10/2002-7/2008</p></li>
<li><p>Bachelor’s Degree in Computer Engineering<br>
Open University of Catalonia, Spain<br>
1/2016-1/2023</p></li>
<li><p>Ph.D.&nbsp;in Medicine<br>
Excellent Cum Laude and extraordinary doctorate award<br>
Autonomous University of Barcelona, Spain<br>
10/2011-11/2014</p></li>
<li><p>Ph.D.&nbsp;in Bioinformatics<br>
Excellent Cum Laude and extraordinary doctorate award<br>
Open University of Catalonia, Spain<br>
6/2018-12/2020</p></li>
<li><p>Internal Medicine Residency<br>
Vall d’Hebron University Hospital, Barcelona, Spain<br>
5/2009-5/2014</p></li>
<li><p>Inflammatory Muscle Diseases Clinical Fellowship<br>
Muscle Disease Unit, NIAMS/NIH<br>
Bethesda, United States of America<br>
7/2018-1/2021</p></li>
<li><p>Master of Research Methodology in Health Sciences<br>
Autonomous University of Barcelona, Spain<br>
11/2011-4/2015</p></li>
<li><p>Master of Advanced Studies in Molecular Medicine<br>
University of Santiago de Compostela, Spain<br>
7/2008-9/2010</p></li>
</ul>
</section>
<section id="licensure-and-board-certification" class="level1">
<h1>LICENSURE AND BOARD CERTIFICATION</h1>
<ul>
<li><p>Medical License from the State of Maryland (licensing number D0094618)<br>
9/2023-Present</p></li>
<li><p>Medical License from the State of New York (licensing number 314404)<br>
12/2021-Present</p></li>
<li><p>Senior Medical Staff Accreditation at the National Institutes of Health<br>
7/2018-Present</p></li>
<li><p>Basic Life Support, American Heart Association<br>
2017-Present</p></li>
<li><p>Certificate of the United States Medical Licensing Examination (USMLE)<br>
United States of America and the Educational Commission for Foreign<br>
Medical Graduates (ECFMG certificate number 0-965-550-7)<br>
5/2015-5/2017</p></li>
<li><p>Medical License from the Official College of Doctors of Barcelona<br>
(licensing number 080844846)<br>
5/2009-Present</p></li>
</ul>
</section>
<section id="professional-experience" class="level1">
<h1>PROFESSIONAL EXPERIENCE</h1>
<ul>
<li><p>Associate Research Physician<br>
Muscle Disease Section<br>
NIAMS/NIH<br>
Bethesda, United States of America<br>
5/2024-Present</p></li>
<li><p>Staff Clinician<br>
Muscle Disease Unit<br>
NIAMS/NIH<br>
Bethesda, United States of America<br>
1/2021-Present</p></li>
<li><p>Assistant Professor<br>
Faculty of Computer Science, Multimedia and Telecommunications<br>
Open University of Catalonia<br>
Barcelona, Spain<br>
3/2019-Present</p></li>
<li><p>Clinical Fellow<br>
Muscle Disease Unit<br>
NIAMS/NIH<br>
Bethesda, United States of America<br>
7/2018-1/2021</p></li>
<li><p>Adjunct Assistant Professor<br>
Department of Neurology<br>
Johns Hopkins University<br>
Baltimore, United States of America<br>
11/2017-Present</p></li>
<li><p>Visiting Fellow<br>
Muscle Disease Unit<br>
NIAMS/NIH<br>
Bethesda, United States of America<br>
6/2015-6/2018</p></li>
<li><p>Myositis Association Research Fellow<br>
Muscle Disease Unit<br>
NIAMS/NIH<br>
Bethesda, United States of America<br>
10/2016-6/2018</p></li>
<li><p>Postdoctoral Fellow<br>
Vall d’Hebron Research Institute<br>
Autoimmune Systemic Diseases Unit<br>
Vall d’Hebron University Hospital<br>
Barcelona, Spain<br>
1/2015-6/2015</p></li>
<li><p>Attending Physician<br>
Internal Medicine Department<br>
Sant Rafael Hospital<br>
Barcelona, Spain<br>
5/2014-4/2015</p></li>
<li><p>Attending Physician<br>
Internal Medicine Department<br>
Quiron Dexeus University Hospital<br>
Barcelona, Spain<br>
5/2014-11/2014</p></li>
<li><p>Research Fellow<br>
Myositis Center<br>
Johns Hopkins Hospital<br>
Baltimore, United States of America<br>
10/2013-12/2013</p></li>
<li><p>Internal Medicine Fellow<br>
Department of Internal Medicine<br>
Autoimmune Systemic Diseases Unit<br>
Vall d’Hebron University Hospital<br>
Barcelona, Spain<br>
5/2009-5/2014</p></li>
<li><p>Postgraduate Fellow<br>
Thyroid and Metabolic Diseases Unit<br>
University of Santiago de Compostela<br>
Santiago de Compostela, Spain<br>
10/2008-9/2010</p></li>
<li><p>Research Student<br>
Thyroid and Metabolic Diseases Unit<br>
University of Santiago de Compostela<br>
Santiago de Compostela, Spain<br>
9/2006-9/2008</p></li>
</ul>
</section>
<section id="teaching" class="level1">
<h1>TEACHING</h1>
<ul>
<li><p>Assistant Professor Data Science Master’s Degree<br>
Faculty of Computer Science, Multimedia and Telecommunications<br>
Open University of Catalonia<br>
Barcelona, Spain<br>
9/2019-Present</p></li>
<li><p>Associate Professor accreditation of the National Agency for Quality Assessment and Accreditation of Spain (ANECA)<br>
1/2018</p></li>
<li><p>Ph.D.&nbsp;Director of Marcelo Alvarado-Cardenas with the project: Statins and autoimmunity. Detection methods and importance of anti-HMGCR autoantibodies.<br>
Medicine Department<br>
Autonomous University of Barcelona<br>
Barcelona, Spain 7/2017-10/2018</p></li>
<li><p>Associate Professor<br>
Pathophysiology and Clinical Semiology<br>
Medicine Department<br>
Autonomous University of Barcelona<br>
Barcelona, Spain<br>
9/2014-9/2015</p></li>
</ul>
</section>
<section id="publications" class="level1">
<h1>PUBLICATIONS</h1>
<section id="original-research" class="level2">
<h2 class="anchored" data-anchor-id="original-research">Original research</h2>
<ol type="1">
<li><p><strong>Pinal-Fernandez I*</strong>, Munoz-Braceras S*, Casal-Dominguez M, et al.&nbsp;Pathological autoantibody internalisation in myositis. Ann Rheum Dis 2024.</p></li>
<li><p>Burbelo P, Huapaya JA, Khavandgar Z, Beach M, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Quantification of Autoantibodies Using a Luminescent Profiling Method in Autoimmune Interstitial Lung Diseases. Frontiers in Immunology 2024.</p></li>
<li><p>Najjar R, Alessi H, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Distinct transcript-level expression profiles and unique alternative splicing in inflammatory myopathies. ACR Open Rheumatology 2024.</p></li>
<li><p>Abad C, <strong>Pinal-Fernandez I</strong>, Guillou C, et al.&nbsp;IFN<span class="math inline">\(\gamma\)</span> causes mitochondrial dysfunction and oxidative stress in myositis. Nature Communications 2024</p></li>
<li><p>Fernandez-Codina A, Nevskaya T, Baron M, …, <strong>Pinal-Fernandez I</strong>, Janet E Pope. Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial. Rheumatology 2024.</p></li>
<li><p>Torres-Ruiz J*, <strong>Pinal-Fernandez I*</strong>, Selva-O'callaghan A*, Cambpell B*, et al.&nbsp;Nailfold capillaroscopy findings of a multicentric multiethnic cohort of patients with idiopathic inflammatory myopathies. Clin Exp Rheum 2024.</p></li>
<li><p>Sherman MA, Noroozi Farhadi P, Pak K, et al.&nbsp;Myositis-associated autoantibodies in juvenile myositis are associated with refractory disease and mortality. Arthritis and Rheumatology 2024. <strong>As a member of the Childhood Myositis Heterogeneity Collaborative Study Group.</strong></p></li>
<li><p>Nath A, Walitt B, …, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Deep phenotyping of Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Nature Communications 2024.</p></li>
<li><p>Kleefeld F, Horvath R, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Multi-level profiling unravels mitochondrial dysfunction in Myotonic Dystrophy type 2. Acta Neuropathologica 2023.</p></li>
<li><p>Sherman M, Yang Q, Gutierrez-Alamillo L, et al.&nbsp;Clinical features and immunogenetic risk factors associated with additional autoantibodies in anti-TIF1<span class="math inline">\(\gamma\)</span> juvenile-onset dermatomyositis. Arthritis and Rheumatology 2023. <strong>As a member of the Childhood Myositis Heterogeneity Collaborative Study Group.</strong></p></li>
<li><p>Muñoz-Braceras S, <strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, et al.&nbsp;Identification of unique microRNA profiles in different types of idiopathic inflammatory myopathy. Cells 2023.</p></li>
<li><p>Lopez-Guerra N*, Matas-Garcia A*, …, <strong>Pinal-Fernandez I<sup>#</sup></strong>, Milisenda JC<sup>#</sup>. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmun Rev 2023.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Milisenda JC*, Pak K*, Munoz-Braceras S*, et al.&nbsp;Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis 2023.</p></li>
<li><p>Sherman MA, Pak K, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis. Arthritis Rheumatol 2023.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Quintana A*, Milisenda JC*, Casal-Dominguez M*, et al.&nbsp;Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis. Ann Rheum Dis 2023.</p></li>
<li><p>Nascimiento A, Bruels CC, Donkervoort S, …, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Variants in DTNA cause a mild, dominantly inherited muscular dystrophy. Acta Neuropathologica 2023.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez*</strong>, Pak K, et al.&nbsp;Coordinated local RNA overexpression of complement induced by interferon gamma in myositis. Scientific Reports 2023.</p></li>
<li><p>Milisenda JC*, <strong>Pinal-Fernandez I*</strong>, Lloyd T, et al.&nbsp;The Pattern of MHC Class I Expression in Muscle Biopsies from Patients with Myositis and other Neuromuscular Disorders. Rheumatology 2023.</p></li>
<li><p>Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Zilucoplan in immune-mediated necrotizing myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatology 2022.</p></li>
<li><p>Michelle EH*, <strong>Pinal-Fernandez I*</strong>, Casal-Dominguez M*, et al.&nbsp;Clinical subgroups and factors associated with progression in patients with inclusion body myositis. Neurology 2023.</p></li>
<li><p>Hosono Y*, Sie B*, <strong>Pinal-Fernandez I*</strong>, Pak K*, et al.&nbsp;Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1<span class="math inline">\(\gamma\)</span> autoantibodies. Ann Rheum Dis 2023.</p></li>
<li><p>Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not severe disease features. Rheumatology 2022.</p></li>
<li><p>Lehky T, <strong>Pinal-Fernandez I</strong>, Krakow EF, et al.&nbsp;Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors. Cell Ther Transplant 2022.</p></li>
<li><p>Cuvelier GDE, Schoettler M, Buxbaum N, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplantation and Cellular Therapy 2022.</p></li>
<li><p>Ikenaga C, Date H, Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Muscle transcriptomics shows overexpression of CDH1 in inclusion body myositis. Ann Neurol 2022.</p></li>
<li><p>Trallero-Araguas E, Gil-Vila A, Martinez-Gomez X, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Cancer screening in idiopathic inflammatory myopathies: ten years experience from a single center. Semin Arthritis Rheum 2022.</p></li>
<li><p>Britson K, Ling JP, Braunstein K, Montagne JM, Kastenschmidt JM, Wilson A, Ikenaga C, Tsao W, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med 2021.</p></li>
<li><p>Amici DR, <strong>Pinal-Fernandez I</strong>, Christopher-Stine L, Mammen AL, Mendillo ML. A network of core and subtype-specific gene expression programs in myositis. Acta Neuropathol 2021.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Pak K, Huang W, Selva-O’Callaghan A, et al.&nbsp;Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies. Arthritis Rheumatol 2021.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Pak K*, Gil-Vila A*, Baucells A*, Plotz B*, et al.&nbsp;Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis Rheumatol 2021.</p></li>
<li><p>Sempere-González A, Llaneras-Artigues, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients. Med Clin (Barc) 2021.</p></li>
<li><p>Casal-Dominguez M, <strong>Pinal-Fernandez I</strong>, Derfoul A, et al.&nbsp;The phenotype of myositis patients with anti-Ku autoantibodies. Seminars in Arthritis and Rheumatism 2021.</p></li>
<li><p>Sabbagh SE*, <strong>Pinal-Fernandez I*</strong>, Casal-Dominguez M, et al.&nbsp;Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Clinical Rheumatology 2021.</p></li>
<li><p>Orozco-Galvez O, Fernandez-Codina A, <strong>Pinal-Fernandez I</strong>, Martinez-Valle F, Simo-Perdigo M. Response to treatment in IgG4-related disease assessed by quantitative positron emission tomography-computerized tomography scan. Clinical Nuclear Medicine 2020.</p></li>
<li><p>Montagne JM, Zheng XA, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Ultra-Efficient Short Read Sequencing of Immune Receptor Repertoires. EBioMedicine 2020.</p></li>
<li><p>Sabbagh S, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. Rheumatology (Oxford) 2020.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, Derfoul A, et al.&nbsp;Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Ann Rheum Dis 2020;79:1234-42.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Pak K, et al.&nbsp;The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies. Clin Exp Rheum 2020.</p></li>
<li><p>Milisenda JC*, <strong>Pinal-Fernandez I*</strong>, Lloyd T, et al.&nbsp;Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies. Clin Exp Rheum 2020.</p></li>
<li><p>Fernandez-Codina A, Pinilla B, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Performance of the 2019 ACR/EULAR classification criteria for IgG4-RD and clinical phenotypes in a Spanish multicenter registry (REERIGG4). Rheumatology (Oxford) 2020.</p></li>
<li><p>Romero-Bueno F, Diaz del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, Martínez-Becerra MJ, Sanchez-Pernaute O, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Recommendations for the Treatment of Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. Semin Arthritis Rheum 2020;50:776-90.</p></li>
<li><p>Seto N, Torres-Ruiz JJ, Carmona-Rivera C, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight 2020;5.</p></li>
<li><p>Parks C*, Pak K*, <strong>Pinal-Fernandez I*</strong>, et al.&nbsp;Trim33 (Tif1<span class="math inline">\(\gamma\)</span>) is not required for skeletal muscle development or regeneration but suppresses cholecystokinin expression. Sci Rep 2019;9:18507.</p></li>
<li><p>Mecoli CA, Albayda J, Tiniakou E, Paik JJ, Zahid U, Danoff SK, Casciola-Rosen L, Casal-Dominguez M, Pak K, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Myositis Autoantibodies: A Comparison of Results from the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot. Arthritis Rheumatol 2020;72:192-4.</p></li>
<li><p>Milisenda JC, Garcia AM, Jou C, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining. Med Clin (Barc) 2019;153:437-40.</p></li>
<li><p>Huapaya J, Silhan L, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease. Chest 2019;156:896-906.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Mecoli C*, Casal-Dominguez M*, et al.&nbsp;More prominent muscle involvement in those dermatomyositis patients with anti-Mi2 autoantibodies. Neurology 2019;93:e1768-e77.</p></li>
<li><p>Huapaya JA, Hallowell R, Silhan L, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Long-term treatment with human Immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respir Med 2019;154:6-11.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Pak K*, Casal-Dominguez M*, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Validation of anti-Mi2 autoantibody testing by line blot. Autoimmun Rev 2020;19:102425.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, Derfoul A, et al.&nbsp;Identification of distinctive interferon gene signatures in different types of myositis. Neurology 2019;93:e1193-e204.</p></li>
<li><p>Sabbagh S*, <strong>Pinal-Fernandez I*</strong>, Kishi T, et al.&nbsp;Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis 2019;78:988-95.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Huapaya J, et al.&nbsp;Efficacy and adverse effects of methotrexate compared with azathioprine in the Antisynthetase Syndrome. Clin Exp Rheumatol 2019;37:858-61.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Amici DR*, Parks CA, Derfoul A, et al.&nbsp;Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. Arthritis Rheumatol 2019;71:1371-6.</p></li>
<li><p>Brusca RM, <strong>Pinal-Fernandez I</strong>, Psoter K, et al.&nbsp;The ILD-GAP Risk Prediction Model Performs Poorly in Myositis-Associated Interstitial Lung Disease. Respir Med. 2019;150:63-5.</p></li>
<li><p>Randazzo D, Khalique U, Belanto J, Kenea A, Talsness DM, Olthoff JTJ, Tran MD, Zaal KJ, Pak K, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Persistent upregulation of the <span class="math inline">\(\beta\)</span>-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Hum Mol Genet. 2019;28(7):1117-35.</p></li>
<li><p>Milisenda JC*, Collado MV*, <strong>Pinal-Fernandez I*</strong>, et al.&nbsp;Correlation between quantitative and semiquantitative magnetic resonance imaging and histopathology findings in dermatomyositis. Clin Exp Rheumatol 2019;37:633-40.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Corse A, et al.&nbsp;Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies. Neurology. 2019;92(13):e1416-e26.</p></li>
<li><p>Amici DR*, <strong>Pinal-Fernandez I*</strong>, Pagkatipunan R, et al.&nbsp;Muscle endurance deficits in myositis patients despite normal manual muscle testing scores. Muscle Nerve. 2019;59(1):70-5.</p></li>
<li><p>De Lorenzo R*, <strong>Pinal-Fernandez I*</strong>, Huang W, et al.&nbsp;Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. Neurology. 2018;90(23):e2068-e76.</p></li>
<li><p>Fernandez-Codina A, Pinilla B, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index. Joint Bone Spine. 2018;85(6):721-6.</p></li>
<li><p>Yeker RM*, <strong>Pinal-Fernandez I*</strong>, Kishi T, et al.&nbsp;Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018;77(5):714-9.</p></li>
<li><p>Redondo-Benito A, Curran A, Villar-Gomez A, Trallero-Araguas E, Fernandez-Codina A, <strong>Pinal-Fernandez I</strong>, Rodrigo-Pendas JA, Selva-O’Callaghan A. Opportunistic infections in patients with idiopathic inflammatory myopathies. Int J Rheum Dis. 2018;21:487-96.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Martinez MA, Milisenda JC, et al.&nbsp;Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford). 2018;57:388-96.</p></li>
<li><p>Suarez-Calvet X, Gallardo E, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis. Arthritis Res Ther. 2017;19(1):174.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Casal-Dominguez M*, Huapaya JA*, et al.&nbsp;A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford). 2017;56(6):999-1007.</p></li>
<li><p>Amici DR, <strong>Pinal-Fernandez I</strong>, Mazala DA, et al.&nbsp;Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis. Acta Neuropathol Commun. 2017;5(1):24.</p></li>
<li><p>Fernandez-Codina A, Berastegui C, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Lung transplantation in systemic sclerosis: A single center cohort study. Joint Bone Spine. 2018;85(1):79-84.</p></li>
<li><p>Lloyd TE, <strong>Pinal-Fernandez I</strong>, Michelle EH, et al.&nbsp;Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology. 2017;88(15):1454-60.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Mego M, et al.&nbsp;High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56:386-92.</p></li>
<li><p>Escola-Verge L, <strong>Pinal-Fernandez I</strong>, Fernandez-Codina A, et al.&nbsp;Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study. J Clin Rheumatol. 2017;23(3):155-9.</p></li>
<li><p>Albayda J*, <strong>Pinal-Fernandez I*</strong>, Huang W, et al.&nbsp;Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients. Arthritis Care Res (Hoboken). 2017;69:1771-6.</p></li>
<li><p>Tiniakou E*, <strong>Pinal-Fernandez I*</strong>, Lloyd TE, et al.&nbsp;More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017;56(5):787-94.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Casal-Dominguez M*, Carrino JA, et al.&nbsp;Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2016;76(4):681-7.</p></li>
<li><p>Alvarado-Cardenas M, Marin-Sanchez A, Martinez MA, Martinez-Martinez L, <strong>Pinal-Fernandez I</strong>, Labrador-Horrillo M, et al.&nbsp;Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev.&nbsp;2016;15(12):1161-6.</p></li>
<li><p>Martinez-Valle F, Fernandez-Codina A, <strong>Pinal-Fernandez I</strong>, Orozco-Galvez O, Vilardell-Tarres M. IgG4-related disease: Evidence from six recent cohorts. Autoimmunity Reviews. 2017;16(2):168-72.</p></li>
<li><p>Basharat P, Lahouti AH, Paik JJ, Albayda J, <strong>Pinal-Fernandez I</strong>, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L. Statin-Induced Anti-HMGCR-Associated Myopathy. J Am Coll Cardiol. 2016;68(2):234-5.</p></li>
<li><p>Johnson C, <strong>Pinal-Fernandez I</strong>, Parikh R, et al.&nbsp;Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Lung. 2016;194(5):733-7.</p></li>
<li><p><strong>Pinal-Fernandez I*</strong>, Parks C*, Werner JL, et al.&nbsp;Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. Arthritis Care Res (Hoboken). 2017;69(2):263-70.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Pineda-Sanchez V, Pallisa-Nunez E, et al.&nbsp;Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clinical Rheumatology. 2016(9);35:2339-45.</p></li>
<li><p>Lloyd TE, Christopher-Stine L, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases. Arthritis Care Res (Hoboken). 2016;68(1):66-71.</p></li>
<li><p>Fernandez-Codina A, Simeon-Aznar CP, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017;37(1):75-84.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Pallisa-Nunez E, Selva-O'Callaghan A, et al.&nbsp;Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome. Clin Exp Rheumatol. 2015;33:S136-41.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis. J Rheumatol. 2015;42(8):1448-54.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Pallisa Nunez E, Selva-O'Callaghan A, Castella-Fierro E, Martinez-Gomez X, Vilardell-Tarres M. Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome. Clin Exp Rheumatol. 2014;32(3):404-7.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Selva-O'Callaghan A, Fernandez-Codina A, et al.&nbsp;"Pregnancy in adult-onset idiopathic inflammatory myopathy": report from a cohort of myositis patients from a single center. Semin Arthritis Rheum. 2014;44(2):234-40.</p></li>
<li><p>Armadans-Tremolosa I, Selva-O'Callaghan A, Visauta-Vinacua B, Guilera G, <strong>Pinal-Fernandez I</strong>, Vilardell-Tarres M. Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol. 2014; 33(8):1119-25.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Martin-Pastor M, Ferro-Gallego P, Dominguez-Gerpe L. Ex vivo proton NMR analysis and characterization of thymus lipid metabolites and their variation with age in C57BL/6 mice. Curr Aging Sci. 2011;4(1):57-69.</p></li>
</ol>
</section>
<section id="review-articles" class="level2">
<h2 class="anchored" data-anchor-id="review-articles">Review articles</h2>
<ol type="1">
<li><p>Musai J, Mammen AL, and <strong>Pinal-Fernandez I</strong>. Recent Updates on th Pathogenesis of Inflammatory Myopathies. Curr Rheumatol Rep 2024.</p></li>
<li><p>Beecher G, <strong>Pinal-Fernandez I</strong>, Mammen AL, et al.&nbsp;Immune Checkpoin Inhibitor Myopathy: The Double-Edged Sword of Cance Immunotherapy. Neurology 2024.</p></li>
<li><p>Jammal C, <strong>Pinal-Fernandez I</strong>, Mammen AL. Adult inflammator myopathies: updates on classification and management. Practica Neurology 2024.</p></li>
<li><p>Sevim E., Kobrin D, Casal-Dominguez M, <strong>Pinal-Fernandez I</strong>. Comprehensive Review of Dermatomyositis Treatments - Fro Rediscovered Classics to Promising Horizons. Expert Review o Clinical Immunology 2023.</p></li>
<li><p>Selva-O’Callaghan A, Guillen-del-Castillo A, …, <strong>Pinal-Fernandez I</strong>, Simeon-Aznar C. Systemic Sclerosis-Associated Myopathy: How t Treat. Current Treatment Options in Rheumatology 2023.</p></li>
<li><p>Ogbonnaya-Whittlesey SA, Kobrin D, Casal-Dominguez M, Mammen AL <strong>Pinal-Fernandez I</strong>. Treatment of Immune-Mediated Necrotizin Myopathy. Current Treatment Options in Rheumatology 2023.</p></li>
<li><p>Casal-Dominguez M, <strong>Pinal-Fernandez I</strong>, Mammen AL. Utility o Myositis-Specific Autoantibodies for Treatment Selection i Myositis. Current Treatment Options in Rheumatology 2022.</p></li>
<li><p>Casal-Dominguez M*, <strong>Pinal-Fernandez I*</strong>, Mammen AL. Inhibitin interferon pathways in dermatomyositis: rationale and preliminar evidence. Current Treatment Options in Rheumatology 2021.</p></li>
<li><p>Selva-O’Callaghan A, Romero-Bueno F, Trallero-Araguas E, Gil-Vila A Ruiz-Rodriguez JC, Sanchez-Pernaute O, <strong>Pinal-Fernandez I</strong>. Pharmacologic treatment of anti-MDA5 rapidly progressiv interstitial lung disease. Current Treatment Options i Rheumatology 2021.</p></li>
<li><p>Selva-O’Callaghan A, Gil-Vila A, Simó-Perdigó M, Trallero-Araguás E Alvarado-Cárdenas M, <strong>Pinal-Fernandez I</strong>. PET Scan: Nuclear Medicin Imaging in Myositis. Curr Rheumatol Rep 2019;21:64.</p></li>
<li><p>Selva-O’Callaghan A, Gil-Vila A, Trallero-Araguás E <strong>Pinal-Fernandez I</strong>. Malignancy and Myositis, from Molecular Mimicr to Tumor Infiltrating Lymphocytes. Neuromuscul Disor 2019;29:819-25.</p></li>
<li><p>Selva-O'Callaghan A, <strong>Pinal-Fernandez I</strong>, Trallero-Araguas E Milisenda JC, Grau-Junyent JM, Mammen AL. Classification an management of adult inflammatory myopathies. Lancet Neurolog 2018;17:816-28.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. Dermatomyositis etiopathogenesis: A rebel soldier in the muscle. Curr Opin Rheumatol 2018;30:623-9.</p></li>
<li><p>Selva-O'Callaghan A, Martinez-Gomez X, Trallero-Araguas E, <strong>Pinal-Fernandez I</strong>. The diagnostic work-up of cancer-associated myositis. Curr Opin Rheumatol. 2018;30(6):630-6.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep.&nbsp;2018;20(4):21.</p></li>
<li><p>Selva-O'Callaghan A, Alvarado-Cardenas M, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018:1-10.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc). 2018;150:398-402.</p></li>
<li><p>Casal-Dominguez M, <strong>Pinal-Fernandez I</strong>, Selva-O' Callaghan A. Protocol for dyspnea in inflammatory myopathies. Medicine. 2017;12(29):1729-34.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol. 2016;28(6):619-24.</p></li>
<li><p>Selva-O'Callaghan A, Trallero-Araguas E, Martinez MA, Labrador-Horrillo M, <strong>Pinal-Fernandez I</strong>, Grau-Junyent JM, et al.&nbsp;Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools. Expert Rev Clin Immunol. 2015;11(6):737-47.</p></li>
<li><p>Selva-O'Callaghan A, Alvarado-Cardenas M, Marin A, <strong>Pinal-Fernandez I</strong>. Statins and myositis: the role of anti-HMGCR antibodies. Expert Rev Clin Immunol. 2015;11(12):1277-9.</p></li>
<li><p>Casal Domínguez M, <strong>Pinal-Fernandez I</strong>. [Guidelines for type 2 diabetes mellitus]. Archivos de Medicina. 2014;10(2);1-18.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Selva-O' Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev.&nbsp;2014;13(4-5):379-82.</p></li>
</ol>
</section>
<section id="case-reports" class="level2">
<h2 class="anchored" data-anchor-id="case-reports">Case reports</h2>
<ol type="1">
<li><p><strong>Pinal-Fernandez I</strong>, Kroodsma CT, Mammen AL. Successful treatment of refractory mechanic’s hands with ustekinumab in a patient with the antisynthetase syndrome. Rheumatology (Oxford) 2019;58:1307-8.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Fonollosa-Pla V, Selva-O'Callaghan A. Improvement of the nailfold capillaroscopy after immunosuppressive treatment in polymyositis. QJM. 2016;109(3):205-6.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Garrigasait Vilaseca V, Fernandez-Codina A, Aranda Rodriguez S. [Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome]. Medicina (B Aires). 2014;74(6):474-5.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Callejas-Moraga EL, Roade-Tato ML, Simeon-Aznar CP. Groove sign in eosinophilic fasciitis. Lancet. 2014;384(9956):1774.</p></li>
<li><p>Callejas Moraga EL, <strong>Pinal Fernandez I</strong>, Roade Tato L, Santafe Colomina M. [Littoral cell angioma. An uncommon cause of constitutional syndrome]. Med Clin (Barc). 2015;144(5):239.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Solans-Laque R. The 'sparing phenomenon' of purpuric rash over tattooed skin. Dermatology. 2014;228(1):27-30.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Miranda-Barrio B. Giant aortic aneurysm in Marfan syndrome. QJM. 2014;107(2):155.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Moris Felgueroso M, Trallero Araguas E. [Lanthanum carbonate abdominal foreign bodies]. Med Clin (Barc). 2014;142(9):426.</p></li>
<li><p>Fernandez-Codina A, Aleman C, Simon-Talero M, Salcedo-Allende MT, <strong>Pinal-Fernandez I</strong>, Segura-Garcia A. Sarcoidosis with complications. Intern Emerg Med. 2014;9(7):817-8.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Ferrer Fabrega B, Ramentol Sintas M, Solans Laque R. Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome. Int J Rheum Dis. 2013;16(6):777-9.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Borras A, Mejia E. [Chest pain of 48 hours of evolution in a 41 years-old man]. Med Clin (Barc). 2013;141(9):390-6.</p></li>
<li><p>Andres Cordon JF, <strong>Pinal Fernandez I</strong>, Willekens Morales R, Arderiu Freixa MA. [Recurrent pleural effusion and marked elevation of CA-125 in a patient with pseudo-Meigs' syndrome secondary to a struma ovarii]. Med Clin (Barc). 2013;140(5):237.</p></li>
<li><p>Portela M, <strong>Pinal L</strong>, Olga S, Dalama B. Diabetes insipidus as an atypical presentation of acute myeloid leukemia. Endocrinol Nutr. 2012;59(8):516-7.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Segura Garcia A. [Intrapulmonary solitary fibrous tumor]. Med Clin (Barc). 2012;139(6):276.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Segura-Garcia A. [Tolvaptan in antidiuretic hormone secretion syndrome secondary to treatment with citalopram]. Rev Clin Esp. 2011;211(9):491-2.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Molina Romero I, Sulleiro Igual E, Segura Garcia A. [Massive eosinophilia and cholestatic hepatitis due to Strongyloides stercoralis infection]. Rev Clin Esp. 2011;211(6):e34-6.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>. [Humoral hypercalcemia in mixed endometrial carcinoma]. An Sist Sanit Navar. 2010;33(2):217-9.</p></li>
</ol>
</section>
<section id="editorials" class="level2">
<h2 class="anchored" data-anchor-id="editorials">Editorials</h2>
<ol type="1">
<li><p><strong>Pinal-Fernandez I</strong>, Greenberg S. Type I Interferons in Dermatomyositis Myoblasts: Toxic Effect and a Potential Autocrine Loop. Neurology 2022.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. Amyloid-PET: a new tool for diagnosing IBM. Nat Rev Rheumatol 2019;15:321-2.</p></li>
</ol>
</section>
<section id="letters-correspondence" class="level2">
<h2 class="anchored" data-anchor-id="letters-correspondence">Letters, correspondence</h2>
<ol type="1">
<li><p>Fernandez-Codina A, Nevskaya T, Baron M, …, <strong>Pinal-Fernandez I</strong>, Janet E Pope. Brentuximab vedotin compared to historical controls for severe skin involvement in cutaneous systemic sclerosis. Rheumatology 2024.</p></li>
<li><p>Johnson C, Schiffenbauer AI, Perin J, et al.&nbsp;HLA Alleles Associated with Interstitial Lung Disease in North Americans with Idiopathic Inflammatory Myopathy. Am J Respir Crit Care Med 2022. As a member of the Myositis-ILD Study Group.</p></li>
<li><p>Mammen A, <strong>Pinal-Fernandez I</strong>, Rider L. Conflicting reports of anti-NT5C1a autoantibodies in juvenile myositis: Comment on the article by Rietveld et al.&nbsp;Arthritis Rheumatol 2021.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. Myositis-specific autoantibodies as relevant adjusting variables in myositis research. Correspondence to “From diagnosis to prognosis: Revisiting the meaning of muscle ISG15 overexpression in juvenile inflammatory myopathies” by Hou et al.&nbsp;Arthritis Rheumatol 2021.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, Milisenda JC, Mammen AL. Response to: 'Correspondence on 'Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis'' by Takanashi et al.&nbsp;Ann Rheum Dis 2021.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. Case 22-2019: A 65-Year-Old Woman with Myopathy. N Engl J Med 2019;381:1693-4.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Mammen AL. On using machine learning algorithms to define clinically meaningful patient subgroups. Ann Rheum Dis 2019.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Pak K, Huang W, Mammen AL. Reply to: Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes. Medicine (Baltimore) 2015.</p></li>
<li><p>Selva-O'Callaghan A, Labirua-Iturburu A, <strong>Pinal-Fernandez I</strong>. Antisynthetase Antibodies in World Trade Center Rescue and Recovery Workers With Inflammatory Myositis: Comment on the Article by Webber et al.&nbsp;Arthritis Rheumatol. 2015;67:2791.</p></li>
</ol>
</section>
<section id="book-chapters" class="level2">
<h2 class="anchored" data-anchor-id="book-chapters">Book chapters</h2>
<ol type="1">
<li><p>Selva-O’Callaghan A, Trallero-Araguás E, <strong>Pinal Fernandez I</strong>. Chapter 25: Cancer-Associated Myositis. Managing Myositis. A Practical Guide. Springer Nature Switzerland; 2020.</p></li>
<li><p>Casal-Dominguez M, <strong>Pinal Fernandez I</strong>, A Selva-O´Callaghan. [Chapter 3: Myositis and the lung. Antisynthetase autoantibodies syndrome]. [Advances in inflammatory myopathies]. 1st ed: Marge Books; 2017.</p></li>
<li><p>Selva O' Callaghan A, <strong>Pinal Fernandez I</strong>. [Chapter 13: Journal choice] In: Jimenez Villa J, Amartin Zurro A, Argimon Pallas JM, Vilardell Tarres M, eds.&nbsp;[Biomedical scientific publication]. 2nd ed: Elsevier; 2015:213-22.</p></li>
<li><p><strong>Pinal Fernandez I</strong>, Casal Dominguez M. [Non-biological immunosuppresive drugs] In: CreateSpace, ed.&nbsp;Wikimecum. 1st ed: Internet Medical Publishing; 2015.</p></li>
<li><p>Casal Dominguez M, <strong>Pinal Fernandez I</strong>. [Guidelines for type 2 diabetes mellitus]. 1st ed: Internet Medical Publishing; 2015.</p></li>
<li><p><strong>Pinal Fernandez I</strong>. [Pulmonary embolism] In: CreateSpace, ed.&nbsp;AEMIR emergencies guidebook. 3th ed: Internet Medical Publishing; 2012.</p></li>
</ol>
<p><em>*Co-first authors</em></p>
<p><em><sup>#</sup>Co-last authors</em></p>
</section>
</section>
<section id="oral-presentations" class="level1">
<h1>ORAL PRESENTATIONS</h1>
<ol type="1">
<li><p>Pathogenic autoantibody internalization in myositis. Grand Rounds, Department of Neurology, University of Massachusetts Medical School, 2024.</p></li>
<li><p>Inlammatory myopathies highlights 2023-2024. Meeting of the Spanish group of autoimmune systemic diseases (GEAS) 2024.</p></li>
<li><p>Autoantibodies: From Bench to Bedside and Back Again. 2024 International Annual Patient Conference of the Myositis Association.</p></li>
<li><p>Pathogenic autoantibody internalization in myositis. 15e Journée Interdisciplinaire du Muscle Inflammatoire (JIMI) 2024.</p></li>
<li><p>Myositis Overview. Joint Georgetown – NIAMS Lecture series 2024.</p></li>
<li><p>Non-invasive biopsies and MRI imaging in cGVHD myofasciitis. Cutaneous Chronic GVHD Task Force Planning Meeting 2024.</p></li>
<li><p>Pathogenic autoantibody internalization in myositis. NIAMS Grand Rounds 2024.</p></li>
<li><p>Transcriptomic Signatures of Human Muscle Tissue. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. ACR 2023.</p></li>
<li><p>Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis. Environmental Autoimmunity Group meeting 2023.</p></li>
<li><p>Transcriptional derepression in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. The Brain Conference 2023.</p></li>
<li><p>Deconvoluting phenotypic complexity in myositis: from syndromes to diseases. 23rd Annual Neuromuscular Study Group Scientific Meeting 2022.</p></li>
<li><p>Transcriptomic analysis in myositis: deconvoluting phenotypic complexity. 13<sup>th</sup> International Congress on Autoimmunity 2022.</p></li>
<li><p>The transcriptomic profile of muscle biopsies from patients with immune checkpoint inhibitor-induced myopathy: specific overexpression of the IL6 pathway and increase of IFNG-stimulated genes. 4th Global Conference on Myositis 2022.</p></li>
<li><p>The transcriptomic profile of muscle biopsies from patients with immune checkpoint inhibitor-induced myopathy. NIAMS IRP Scientific Retreat 2022.</p></li>
<li><p>JAK inhibitors in dermatomyositis. 2022 NIH Neuromuscular Journal Club.</p></li>
<li><p>From syndromes to diseases. The Myositis Association scientific symposium 2021.</p></li>
<li><p>Ancillary Studies in Myositis. NIAMS Rheumatology Didactics 2021.</p></li>
<li><p>Autoantibody-based classification in myositis. NIAMS Grand Rounds 2019.</p></li>
<li><p>Muscle MRI in diagnostics and assessment of myositis. ACR 2019.</p></li>
<li><p>Machine Learning on Myositis Transcriptomics (or How to Find a Needle in an RNA Haystack). NIAMS Grand Rounds 2019.</p></li>
<li><p>NIAMS Journal Club (2017-Now).</p></li>
<li><p>The interferon gene signature in dermatomyositis, the anti-synthetase syndrome, immune-mediated necrotizing myopathy, and inclusion body myositis: A comparative study. Global Conference on Myositis 2019 and NIAMS Grand Rounds 2019.</p></li>
<li><p>Grand rounds and teaching at St.&nbsp;Joseph´s Health Care. London (Ontario) 2018.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, B Ferrer-Fabregas, E Trallero-Araguas, E Balada, MA Martinez, JC Milisenda, G Aparicio-Español, M Labrador-Horrillo, V Garcia-Patos, JM Grau-Junyent, A Selva-O’Callaghan. Tumor TIF1 Mutations and Loss of Heterozygosity Related to Cancer Associated Myositis. ACR 2017.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, W Huang, M Casal-Dominguez, E Tiniakou, C Parks, K Pak, J Albayda, JJ Paik, DK Danoff, L Christopher-Stine, AL Mammen. Myositis Autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. EULAR 2017.</p></li>
<li><p>D Amici, <strong>I Pinal-Fernandez</strong>, D Mazala, T Lloyd, A Corse, L Christopher-Stine, A Mammen, E Chin. Calcium Dysregulation, Functional Calpainopathy, and Endoplasmic Reticulum Stress in Sporadic Inclusion Body Myositis. Global Conference on Myositis 2017.</p></li>
<li><p>R Yeker, <strong>I Pinal-Fernandez</strong>, T Kishi, IN Targoff, FW Miller, LG Rider, A Mammen. Anti-NT5C1A autoantibodies are frequent in juvenile myositis and associated with increased illness severity. Global Conference on Myositis 2017.</p></li>
<li><p>M. Alvarado-Cardenas, A. Marin, M.A.&nbsp;Martinez, <strong>I. Pinal-Fernandez</strong>, M. Labrador-Horrillo, P.J. Moreno, J.C. Millisenda, J.M. Grau, R. Pujol, C. Juárez, A. Selva-O'Callaghan. Distinctive Immunofluorescence Pattern in Statin-Associated Autoimmune Myopathy with Anti-HMGCR Autoantibodies. EULAR 2016.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, A Lahouti, P Basharat, M Albayda, J Paik, S Ahlawat, S Danoff, T Lloyd, A Mammen, J Carrino, L Christopher-Stine. Thigh magnetic resonance imaging reveals increased active and chronic muscle damage in necrotizing myositis compared to polymyositis and dermatomyositis. EULAR 2016.</p></li>
<li><p>A. Fernández-Codina, <strong>I. Pinal-Fernández</strong>, I. De Torres-Ramírez, B. Pinilla, C. López, T. Rosiñol, M. Núñez-Fernández, F. Martínez-Valle. Update of the IgG4 spanish registry after one year and a half. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015.</p></li>
<li><p>Great Syndromes in Medicine. Translational Biomedical Research Master. Vall d’Hebron Reseach Institute (VHIR) and Autonomous University of Barcelona (2014).</p></li>
<li><p><strong>Pinal-Fernandez I</strong>. Myositis activity measures. VII Autoimmune and Systemic Diseases National Meeting (2014).</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Casciola-Rosen L, Christopher-Stine L, Corse A, Mammen A. Distinct Autoantibodies Associate with Specific Histological Abnormalities in Dermatomyositis. Myositis Study Group Meeting (2014).</p></li>
<li><p><strong>Pinal-Fernandez I</strong>. Clinical Case. VI School of Internal Medicine for residents (2014).</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Yagüe MI, Pecorelli R, Navarro A, Mellibovsky L. Cutaneous lesions and rapidly progressive pneumonitis. Parc de Salut MAR general sessions (2013).</p></li>
<li><p>Fernández-Codina A, Silveira M, <strong>Pinal Fernández I</strong>, Guillén del Castillo A, Simeón Aznar C, Fonollosa Plà V, Román Broto A, Vilardell Tarrés M. Lung transplantation in systemic sclerosis. Experience from a single reference center. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI 2013).</p></li>
<li><p>Fernández Viñas M, Pallisa Núñez E, Castella Fierro E, <strong>Pinal Fernández I</strong>, Andreu Soriano J, Gaete González J. Transthoracic echography and HRCT in the follow-up of lung disease due to systemic sclerosis. V national congress of Catalonian radiologists 2013</p></li>
<li><p>Armadans I, Selva O’Callaghan A, Visauta B, <strong>Pinal-Fernandez I</strong>, Juanós Iborra M, Cassá N, Guillén A, Vilardell Tarrés M. Well-being and quality of life in patients with inflammatory myopathy. 11th congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI 2012)</p></li>
<li><p>Labirua A, Selva O’Callaghan A, Zock J, Orriols R, Martínez Gómez X, Juanós M, <strong>Pinal-Fernandez I</strong>, Vilardell M. Occupational exposures and clinical characteristics in patients with the antisynthetase syndrome. 11th Congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI 2012)</p></li>
<li><p><strong>Pinal Fernández I</strong>. NMR Determination of fat content in the thymus of C57BL / 6. Analysis of its variation with age. I Iberian Congress of Medical Students (CARES 2007)</p></li>
<li><p><strong>Pinal Fernández I</strong>, Río Gómez A, Rodil Rodil V, Dosantos Carregal L. Predictors of Sudden Death and Heart Failure in Patients with Refractory Heart Failure. XII Congress of Cardiology for Students (CARES 2006)</p></li>
<li><p><strong>Pinal Fernández I</strong>, Montes de Oca Pallas D. Anemia in mortality from heart failure. Coincidence or something more?. XI Congress of Cardiology for Students (CARES 2005).</p></li>
</ol>
</section>
<section id="posters" class="level1">
<h1>POSTERS</h1>
<ol type="1">
<li><p>Pinal-Fernandez I, Ruffer N, Casal-Dominguez M, et al.&nbsp;Specific Transcriptomic Profile Associated with Disease Activity in Muscle Biopsies from Patients with Sarcoid Myopathy. ACR 2024.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Reay D, Oriss T, Pak K, et al.&nbsp;Comparative Transcriptional Profiling Reveals Shared Pathway Activation Between Human Jo-1+ Anti-Synthetase Syndrome and Murine Histidyl-tRNA Synthetase-Induced Myositis. ACR 2024.</p></li>
<li><p>Kirou R, <strong>Pinal-Fernandez I</strong>, and Andrew Mammen. Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Subtypes of Inflammatory Myopathies. ACR 2024.</p></li>
<li><p>Zhang Y, Ross B, Galvan1 D, Bao Y, Matsuda D, Grosskurth S, <strong>Iago Pinal-Fernandez</strong>, et al.&nbsp;Effective Engineering of CD8+ T Cells from Autoimmune Disease Patients Utilizing a CD8-Targeted Lipid NanoparticleEncoding an Anti-CD19 CAR mRNA(CPTX2309). ACR 2024.</p></li>
<li><p>Casal-Dominguez M, <strong>Pinal-Fernandez I</strong>, Muñoz-braceras S, et al.&nbsp;Antisynthetase Autoantibodies Disrupt the Function of Their Target Aminoacyl-tRNA Synthetases in Muscle Cells. ACR 2024.</p></li>
<li><p>Musai J, Jayaraman S, Pak K, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Anti-Mi2 Autoantibodies in Dermatomyositis Patients Also Recognize Autoimmune Regulator (AIRE) Protein. ACR 2024.</p></li>
<li><p>Casal-Dominguez M, Milisenda J, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Transcriptomic profiles in muscle biopsies from systemic sclerosis patients with different autoantibodies. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Gil-Vila A, Moreno-Cardenas AB, …, <strong>Pinal-Fernandez I</strong>, …, et al.&nbsp;Tumors from cancer-associated myositis harbor genetic events in myositis-specific autoantigens. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Milisenda J, <strong>Pinal-Fernandez I</strong>, Pak K, et al.Lipid droplets in immune-mediated necrotizing myositis. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Muñoz-Braceras S, <strong>Pinal-Fernandez I</strong>, Casal-Dominguez, et al.&nbsp;Myositis-specific autoantibodies induce distinct transcriptomic signatures in human skeletal muscle myoblasts. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Musai J, Jayaraman S, Pak K, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Autoantibodies recognizing aire detected in anti-mi2-positive dermatomyositis. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Ogbonnaya-Whittlesey SA, <strong>Pinal-Fernandez I</strong>, Mammen AL. Fascial thickness in inflammatory myopathies. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Milisenda J, <strong>Pinal-Fernandez I</strong>, Pak K, et al.&nbsp;Muscle pathology in patients with primary biliary cholangitis. 5th Global Conference on Myositis 2024.</p></li>
<li><p>Najjar R, <strong>Pinal-Fernandez I</strong>, Mammen AL, et al.&nbsp;Alternative Splicing and Expected Protein Changes in Muscle Biopsies from Different Types of Idiopathic Inflammatory Myopathies. ACR 2023.</p></li>
<li><p>Casal-Dominguez M, Milisenda JC, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Transcriptomic Profiles in Muscle Biopsies from Systemic Sclerosis Patients with Different Autoantibodies. ACR 2023.</p></li>
<li><p>Sherman M, Noroozi Farhad P, Trieu E, …, <strong>Pinal-Fernandez I</strong>, …, et al.&nbsp;Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome. ACR 2023.</p></li>
<li><p>Milisenda JC, <strong>Pinal-Fernandez I</strong>, Pak K, et al.&nbsp;Muscle Pathology in Patients with Primary Biliary Cholangitis. ACR 2023.</p></li>
<li><p>M Casal-Dominguez, <strong>I Pinal-Fernandez</strong>, K Pak, et al.&nbsp;RNA-sequencing of the complement genes in the muscle biopsies of autoimmune myopathies. 4th Global Conference on Myositis 2022.</p></li>
<li><p>S Munoz-Braceras, <strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, et al.&nbsp;Analysis of miRNA expression profiles of myositis subgroups in muscle biopsies. 4th Global Conference on Myositis 2022 and NIAMS IRP Scientific Retreat 2019.</p></li>
<li><p>J Torres-Ruiz, K Pak, <strong>I Pinal-Fernández</strong>, et al.&nbsp;Spatial transcriptomic analysis of dermatomyositis muscle unveils a unique signature in atrophic perifascicular muscle fibers. 4th Global Conference on Myositis 2022.</p></li>
<li><p>J Ros, A Gil-Vila, J Lostes, P Nuciforo, C Vilaplana, E Trallero-Araguás, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;Immunogenetics features of dermatomyositis-associated malignancies. 4th Global Conference on Myositis 2022.</p></li>
<li><p>MA Sherman, R Graf, AS Galindo-Feria, SE Sabbagh, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;Anti-FHL1 autoantibodies in juvenile myositis are associated with myositis-associated autoantibodies but not distinctive clinical features. 4th Global Conference on Myositis 2022.</p></li>
<li><p>JC Milisenda, <strong>I Pinal-Fernandez</strong>, TE Lloyd, et al.&nbsp;The Pattern of Major Histocompatibility Complex Class I Expression in Muscle Biopsies from Patients with Different Types of Myositis and other Neuromuscular Disorders. 4th Global Conference on Myositis 2022.</p></li>
<li><p>C Zhao, M Mule, A Martins, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;540 Baseline mTOR transcriptional signatures in CD8 T cells are associated with immune-related adverse events but not anti-tumor responses in patients receiving immune checkpoint inhibitors. 36 Annual Meeting of the The Society for Immunotherapy of Cancer 2021.</p></li>
<li><p>M Casal-Dominguez, <strong>I Pinal-Fernandez</strong>, A Mammen. Local complement overexpression in the muscle biopsies of patients with inflammatory myopathies. NIAMS IRP Scientific Retreat 2021.</p></li>
<li><p>Sabbagh S, <strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, et al.&nbsp;Anti-mitochondrial Autoantibodies Are Associated with Cardiomyopathy, Dysphagia, and Features of More Severe Disease in Adult-onset Myositis. ACR 2020.</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Pak K, Gil-Vila A, et al.&nbsp;Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis. ACR 2020.</p></li>
<li><p>Sabbagh S, Neely J, Chow A, …, <strong>Pinal-Fernandez I</strong>, et al.&nbsp;Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America. ACR 2020.</p></li>
<li><p>Sabbagh S, <strong>Pinal-Fernandez I</strong>, Casal-Dominguez M, et al.&nbsp;Anti-Mitochondrial Autoantibodies Are Associated with Dysphagia in Juvenile and Adult Myositis, and with Persistent Weakness and Cardiomyopathy in Adult Myositis. ACR 2020.</p></li>
<li><p>M Casal-Dominguez, <strong>I Pinal-Fernandez</strong>, K Pak, et al.&nbsp;Autoantibodies outperform the ACR/EULAR classificatory myositis criteria in adult myositis patients. NIAMS IRP Scientific Retreat 2020.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, Assia Derfoul, et al.&nbsp;Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. NIAMS IRP Scientific Retreat 2020.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, A Derfoul, et al.&nbsp;Identification of Distinctive Interferon Gene Signatures in Different Types of Inflammatory Myopathy. ACR 2019.</p></li>
<li><p>M Casal-Dominguez, <strong>I Pinal-Fernandez</strong>, A Marin, et al.&nbsp;Frequency and Staining Patterns of Antinuclear Antibodies in Myositis Patients Without Known Myositis-specific Autoantibodies. ACR 2019.</p></li>
<li><p>S Sabbagh, <strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, et al.&nbsp;Anti-mitochondrial Autoantibodies in Idiopathic Inflammatory Myopathies. ACR 2019.</p></li>
<li><p>A Fernandez-Codina, B Pinilla, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;Use of the provisional EULAR/ACR Igg4-RD classification criteria in a cohort of spanish patients. EULAR 2019.</p></li>
<li><p>B Kisluk, J Milisenda, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;Muscle involvement in systemic sclerosis. EULAR 2019.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, A Derfoul, et al.&nbsp;The interferon gene signature in dermatomyositis, the anti-synthetase syndrome, immune-mediated necrotizing myopathy, and inclusion body myositis: A comparative study. NIAMS IRP Scientific Retreat 2019.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, K Pak, M Casal-Dominguez, et al.&nbsp;Validation of anti-Mi2 autoantibody testing by line blot. NIAMS IRP Scientific Retreat 2019.</p></li>
<li><p>J Milisenda, <strong>I Pinal-Fernandez</strong>, T. Lloyd, et al.&nbsp;The prevalence of p62 immunostaining in muscle biopsies from patients with myositis, non-inflammatory myopathies, and neurogenic disorders. Global Conference on Myositis 2019</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, D Amici, C Parks, et al.&nbsp;Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. Global Conference on Myositis 2019</p></li>
<li><p>J Ros, J Lostes, P Nuciforo, C Viaplana, J Milisenda, E Trallero-Araguas, <strong>I Pinal-Fernandez</strong> et al.&nbsp;Tumour Infiltrating Lymphocytes quantification in Cancer-Associated Dermatomyositis. Global Conference on Myositis 2019</p></li>
<li><p>A Gil-Vila, E Trallero-Araguas, M Alvarado-Cardenas, <strong>I Pinal-Fernandez</strong>, et al.&nbsp;Reliability of PET/TC cancer screening in a large cohort of patients diagnosed with idiopathic inflammatory myopathy. Global Conference on Myositis 2019</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, K. Pak, M. Casal-Dominguez, W. Huang, J. Albayda, E. Tiniakou, J.J. Paik, C.A. Mecoli, S.K. Danoff, L. Christopher-Stine, A.L. Mammen. Longitudinal Course of the Disease in Anti-Mi2 Patients: More Intense Muscle Weakness, Good Response to Treatment and Progressive Reduction of Autoantibody Titers. ACR 2018 and NIAMS IRP Scientific Retreat 2019</p></li>
<li><p>S. Sabbagh, I. <strong>Pinal-Fernandez</strong>, T Kishi, I.N. Targoff, F.W. Miller, L.G. Rider, A. Mammen. Association of Anti-Ro52 Autoantibodies with Interstitial Lung Disease and More Severe Disease Manifestations in Juvenile Idiopathic Inflammatory Myopathies. ACR 2018, Global Conference on Myositis 2019 and NIAMS IRP Scientific Retreat 2019</p></li>
<li><p>Y. Hosono, I. <strong>Pinal-Fernandez</strong>, K. Pak, J. Albayda, E. Tiniakou, J.J. Paik, C.A. Mecoli, S.K. Danoff, L. Christopher-Stine, A. Mammen. Anti-Splicing Factor Proline/Glutamine-Richautoantibodies Rarely Co-Exist with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies in a Cohort of Dermatomyositis Patients from the United States. ACR 2018</p></li>
<li><p>D. Amici, I. <strong>Pinal-Fernandez</strong>, R. Pagkatipunan, A. Mears, R. De Lorenzo, E. Tiniakou, J Albayda, J.J. Paik, T. Lloyd, L. Christopher-Stine, A. Mammen, Tae Chung. Muscle Endurance Deficits in Myositis Patients Despite Normal Manual Muscle Testing Scores. ACR 2018</p></li>
<li><p>M. Casal-Dominguez, I. <strong>Pinal-Fernandez</strong>, A. Corse, JJ. Paik, J. Albayda, L. Casciola-Rosen, C. Johnson, S. Danoff, L. Christopher-Stine, E. Tiniakou, A. Mammen. Myositis Patients with Anti-U1-RNP and Anti-Ro52 Autoantibodies Are at Risk of Pericarditis, Glomerulonephritis, and Pulmonary Hypertension. ACR 2018</p></li>
<li><p>C. Johnson, R. McKibben, I. <strong>Pinal Fernandez</strong>, K. Psoter, J. Paik, M. Albayda, C. Mecoli, E. Tiniakou, A. Mammen, L. Christopher-Stine, S.K. Danoff. The ILD-GAP Risk Prediction Model Performs Poorly in Patients with Myositis-Associated ILD. ATS 2018</p></li>
<li><p>R De Lorenzo, <strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, W Huang, JC Milisenda, C Parks, K Pak, C Johnson, E Tiniakou, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, A Corse, A Mammen. Longitudinal cohort study of anti-PM/Scl myositis patients: mild muscle and lung involvement with prominent perivascular inflammation. ACR 2017</p></li>
<li><p>M Casal-Dominguez, <strong>I Pinal-Fernandez</strong>, C Johnson, A Mammen, J Albayda, J Huapaya, L Christopher-Stine, SK Danoff, LL Silhan, JJ Paik. Efficacy and Adverse Effects of Methotrexate Compared with Azathioprine in the Antisynthetase Syndrome. Global Conference on Myositis 2017.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, W Huang, M Casal-Dominguez, E Tiniakou, C Parks, K Pak, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, AL Mammen. Myositis Autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.</p></li>
<li><p>C Parks, <strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, J Albayda, JJ Paik, SK Danoff, L Christopher-Stine, L Casciola-Rosen, AL Mammen. Activity of Autoantibody Titers Against SRP Subunits and SRP RNA in Anti-SRP–associated Myopathy. Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.</p></li>
<li><p>A Fernandez-Codina, <strong>I Pinal-Fernandez</strong>, B Pinilla, C Lopez, R Solans-Laque, G Fraile-Rodriguez, E Fonseca- Aizpuru, JM Cameselle-Tejeiro, S Prieto-Gonzalez, J Pardos-Gea, J Gil, T Rossinyol, MJ Nuñez-Fernandez, G Salvador-Cervello, F Martinez-Valle. Treatment and outcomes in Spanish patients with IgG4-related disease. EULAR 2017.</p></li>
<li><p>R Yeker, <strong>I Pinal-Fernandez</strong>, T Kishi, IN Targoff, FW Miller, LG Rider, A Mammen. Anti-NT5C1A autoantibodies are frequent in juvenile myositis and associated with increased illness severity. EULAR 2017, ACR 2017 and NIAMS IRP Scientific Retreat 2017.</p></li>
<li><p>A Redondo-Benito, A Curran-Fabregas, A Villar-Gomez, E Trallero-Araguas, A Fernandez-Codina, <strong>I Pinal-Fernandez</strong>, A Selva-O´Callaghan. Opportunistic infections in patients with myositis. A retrospective cohort study. EULAR 2017.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Casal-Dominguez, JA. Carrino, A Lahoutiharahdashti, P Basharat, J Albayda, JJ Paik, S Ahlawat, SK Danoff, TE Lloyd, A Mammen, L Christopher-Stine. Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy. ACR 2016.</p></li>
<li><p>A Fernández-Codina, <strong>I Pinal-Fernández</strong>, O Orozco-Gálvez, R Solans-Laqué, S Bujan-Rivas, V Fonollosa-Plà, M Vilardell-Tarrés, F Martínez-Valle. Use of disease-modifying anti-rheumatic drugs in a cohort of patients with IgG4-related disease. EULAR 2016.</p></li>
<li><p>E Tiniakou, <strong>I Pinal Fernandez</strong>, L Christopher-Stine, J Werner, T Lloyd, J Paik, J Albayda, S Danoff, A Mammen. Slow recovery of muscle strength in young anti-HMG-CoA reductase positive myopathy patients. EULAR meeting 2016.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, C Parks, E Tiniakou, M Albayda, J Paik, A Lahouti, M Casal-Dominguez, K Pak, W Huang, TE Lloyd, S Danoff, L Casciola-Rosen, L Christopher-Stine, AL Mammen. Anti-SRP-associated autoimmune myopathy: younger age at onset is associated with more severe disease and worse outcome. EULAR 2016, Global Conference on Myositis 2017 and NIAMS IRP Scientific Retreat 2017.</p></li>
<li><p>H. Ilieva, I. <strong>Pinal Fernandez</strong>, P. Natov, E. Mosmiller, L. Clawson, E. Simpson, S. Appel, N Maragakis. Earlier Disease Onset in Non-Caucasian Amyotrophic Lateral Sclerosis (ALS) Patients: Retrospective Analysis from Two Tertiary Centers. American Academy of Neurology Meeting 2016.</p></li>
<li><p>A. Lahoutiharahdashti, I. <strong>Pinal-Fernandez</strong>, J. Albayda, J.J. Paik, S.K. Danoff, A. Mammen, L. Christopher-Stine. Autoimmune Myopathies: Effects of Intravenous Immunoglobulin Therapy on Muscle Strength and Predictors of Response. ACR/ARHP Meeting 2015.</p></li>
<li><p>M. Albayda, I. <strong>Pinal-Fernandez</strong>, L. Christopher-Stine, S.K. Danoff, C. Johnson, C. Mecoli, J.J. Paik, A. Ramji, A. Mammen. Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody. ACR/ARHP Meeting 2015.</p></li>
<li><p>E. Tiniakou, I. <strong>Pinal-Fernandez</strong>, L. Christopher-Stine, J. Werner, T. E. Lloyd5, J.J. Paik, J. Albayda, S.K. Danoff, A. Mammen. Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive Myopathy Patients without Statin Exposure May Have a Progressive Disease That Worsens Despite Aggressive Immunosuppressive Therapy. ACR/ARHP Meeting 2015.</p></li>
<li><p>A. Fernández-Codina, I. <strong>Pinal-Fernández</strong>, O. Orozco-Gálvez, R. Solans-Laqué, S. Buján-Rivas, M. Vilardell-Tarrés, F. Martínez-Valle. Use of disease-modifying antirheumatic drugs in a cohort of patients with IgG4 related disease. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015</p></li>
<li><p>P. Basharat, A Lahouti H., A.L. Mammen, I. <strong>Pinal-Fernandez</strong>, T Bichile, T. E. Lloyd, S.K. Danoff, L. Casciola-Rosen, L Christopher-Stine. Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase. ACR/ARHP Meeting 2014</p></li>
<li><p>T.E. Lloyd, I.<strong>Pinal-Fernandez</strong>, L. Christopher-Stine, J.S. Mammen, A.L. Mammen. Overlapping features of inclusion body myositis (IBM) and polymyositis (PM) in human immunodeficiency virus (HIV)-infected patients. Myositis Study Group Meeting 2014</p></li>
<li><p>Johnson C, <strong>Pinal-Fernandez I</strong>, Paik J, Albayda J, Mammen AL, Christopher-Stine L, et al.&nbsp;Assessment Of Mortality In Autoimmune Myositis With And Without Associated Interstitial Lung Disease. American Thoracic Society congress; 2014.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, V Pineda-Sanchez, E Pallisa Núñez, CP Simeón-Aznar, A Selva-O´Callaghan. Comparison of fast 1.5t chest MRI with HRCT scan in the assessment of interstitial lung disease extension secondary to systemic sclerosis. EULAR congress 2014.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, A Selva-O’Callaghan, A Fernandez-Codina, X Martinez-Gomez, J Angel Rodrigo-Pendas, J Perez-Lopez, M Vilardell-Tarres. Pregnancy in adult-onset idiopathic inflammatory myopathy. Report from a cohort of myositis patients from a single center. EULAR congress 2014.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, M Del Grande, F Del Grande, J Carrino, A Mammen, T Lloyd, L Christopher-Stine. Association between muscle enzymes, acute-phase reactants and MRI findings in myositis. EULAR congress 2014.</p></li>
<li><p><strong>I Pinal-Fernandez</strong>, L Christopher-Stine, L Casciola-Rosen, A Corse, A Mammen. Correlating muscle biopsy features with autoantibodies in patients with dermatomyositis and the jo-1 antisynthetase syndrome. EULAR congress 2014.</p></li>
<li><p>I. <strong>Pinal Fernández</strong>, A. Selva OCallaghan, A. Codina, J. Rodrigo Pendas, X. Martínez Gómez, M. Juanós Iborra, J. Pérez López, M. Vilardell Tarrés. Idiopathic inflammatory myopathy and pregnancy. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI) 2013</p></li>
<li><p>I. <strong>Pinal Fernández</strong>, C. Simeón Aznar, A. Selva OCallaghan, E. Pallisa Núñez, V. Pineda, A. Fernández Codina, V. Fonollosa Plà, M. Vilardell Tarrés. Correlation between nuclear magnetic resonance and HRCT for the study of the interstitial lung disease due to systemic sclerosis. XXXIV National Congress of the Spanish Society of Internal Medicine (SEMI) 2013</p></li>
<li><p>J. Perez-Lopez, A. Selva-O'Callaghan, J. C. Milisenda, L. Gallego, E. Trallero-Araguas, M. Juanos-Iborra, <strong>I. Pinal</strong>, J. M. Grau-Junyent, M. Vilardell-Tarrés. Adult pompe's disease: screening in patients with myopathies of unknown etiology. EULAR congress 2013</p></li>
<li><p>A. Labirua Iturburu, A. Selva O’Callaghan, X. Martínez Gómez, E. Trallero Araguás, M. Juanós Iborra, <strong>I. Pinal</strong>, M. Labrador Horrillo, M. Vilardell Tarrés. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. An observational study. 11th congress of the European Federation of Internal Medicine and XXXIII and National Congress of the Spanish Society of Internal Medicine (SEMI) 2012</p></li>
<li><p>Usefulness of thoracic ecography in patients affected by antisynthetase syndrome. XXXII National Congress of the Spanish Society of Internal Medicine (SEMI) and XIV Congress of the Canarian Society of Internal Medicine 2011</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Pallisa-Nuñez E, Castella Fierro E, Martínez-Gómez X, Simeon Aznar C, Muñoz Gall X, Sureda D, Selva O´Callaghan A.</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Mayorga-Gomez L, Gallardo-Jimenez P. Achromobacter xylosoxidans-infection. XV National Congress of the Spanish Society of Clinical Microbiology and Infectious Diseases 2011</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Segura-García A. Tolvaptan in the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) secondary to treatment with citalopram. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010 and XIV Congress of the Catalanobalearian Society of Internal Medicine 2011</p></li>
<li><p><strong>Pinal-Fernández I</strong>. Humoral hypercalcemia secondary-mixed endometrial carcinoma. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Portela M. Diabetes insipidus secondary-AML M2 trilinear dysplasia, deletion of chromosome 7 and 3q21:q26 inversion. XXII Congress of the Valencian Society of Endocrinology and Nutrition 2010</p></li>
<li><p><strong>Pinal-Fernandez I</strong>, Martin-Pastor M, Bravo S, Ferro Gallego P, Lago-Leston R, Alvarez C, Domínguez-Gerpe ML. Metabolomic profiles of hydrophilic and lipophilic extracts from thyroid cell line and Pathological Tissues normal by 1H NMR spectroscopy. 34 Congress of the Federation of European Biochemical Societies (FEBS) 2009</p></li>
<li><p>Ferro-Gallego P, Lago-Leston A, <strong>Pinal-Fernández I</strong>, Castro-Gago M and Domínguez-Gerpe ML. New case: a female patient in the mosaicism With A SLC16A2 gene encoding the thyroid hormone specific transporter monocarboxylate transporter 8 (MCT8). 34 Congress of the Federation of European Biochemical Societies (FEBS) 2009</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Martín-Pastor M, Lado-Abeal J, Araujo-Vilar D, Domínguez-Gerpe ML. NMR / MRI study of the age-associated Involution of the thymus in C57BL / 6 mice. I Iberian Meeting of NMR 2008</p></li>
<li><p><strong>Pinal-Fernández I</strong>, Ferro-Gallego P, Martín-Pastor M, Dominguez Gerpe ML. Quantitative and Qualitative Changes in the thymus cellularity of mice With Age Determined by NMR spectroscopy. 33 Congress of the Federation of European Biochemical Societies (FEBS) and 11 International Congress of Biochemistry and Molecular Biology (IUMBM) 2008</p></li>
<li><p>Iglesias Fungueiro MJ, Viéitez Rodríguez O, <strong>Pinal Fernández I</strong>, et al.&nbsp;Influence of the S33P polymorphism of monocarboxylates 8 (MCT8) on serum TSH and thyroid hormones in a population of healthy male volunteers of Galicia. 48 National Congress of the Spanish Society of Endocrinology and Nutrition 2006</p></li>
</ol>
</section>
<section id="conferences-and-courses" class="level1">
<h1>CONFERENCES AND COURSES</h1>
<ol type="1">
<li><p>International Annual Patient Conference of the Myositis Association (2024)</p></li>
<li><p>15e Journée Interdisciplinaire du Muscle Inflammatoire (JIMI, 2024)</p></li>
<li><p>Global Conference on Myositis (2015, 2017, 2022, 2024)</p></li>
<li><p>NIAMS IRP Scientific Retreat (2016-2024)</p></li>
<li><p>23rd Annual Neuromuscular Study Group Scientific Meeting (2022)</p></li>
<li><p>13<sup>th</sup> International Congress on Autoimmunity (2022)</p></li>
<li><p>ACR/ARHP Annual Meeting (2016-23)</p></li>
<li><p>2018 Update on Juvenile Myositis Care and Research (The George Washington University School of Medicine and Public Health 2018)</p></li>
<li><p>Advanced Studies in Bioinformatics and Data Science (Foundation for Advanced Education in the Sciences, National Institutes of Health, 2015-2018):</p>
<ol type="a">
<li><p>Introduction to New Technologies in Data Science 2018</p></li>
<li><p>Theoretical and Applied Bioinformatics 2017</p></li>
<li><p>Super R with Shiny 2017</p></li>
<li><p>Machine Learning and Object-Oriented Programming with Python 2016</p></li>
<li><p>Bioinformatics for Analysis of Data Generated by Next Generation Sequencing 2016</p></li>
<li><p>Introduction to Python 2015</p></li>
</ol></li>
<li><p>Medium level certificate of competencies in information and communication technologies (UOC 2016-17).</p></li>
<li><p>EULAR Congress (2013, 2014, 2016, 2017)</p></li>
<li><p>Completion of the NIH Clinical Research Curriculum Certificate (2017)</p></li>
<li><p>XXXVIII National Congress of the Spanish Society of Internal Medicine (2016)</p></li>
<li><p>Introduction to the Principles and Practice of Clinical Research 2016 (National Institutes of Health Clinical Center)</p></li>
<li><p>VII Autoimmune and Systemic Diseases National Meeting (2014)</p></li>
<li><p>Myositis Study Group Meeting (2014)</p></li>
<li><p>VI School of Internal Medicine for residents (2014)</p></li>
<li><p>2nd ESF-Sponsored International Myositis Genetics Workshop (2014)</p></li>
<li><p>Scientific redaction and publication (Ibero-American Nature Publishing Group) (2013)</p></li>
<li><p>Seminar of Clinical Research of the European Federation of Internal Medicine (2013)</p></li>
<li><p>3rd European School of Internal Medicine (2013)</p></li>
<li><p>11th Congress of the European Federation of Internal Medicine and XXXIII National Congress of the Spanish Society of Internal Medicine (2012)</p></li>
<li><p>V Autoimmune and Systemic Diseases National Meeting (2012)</p></li>
<li><p>VI Actualization National Meeting for Residents in Autoimmune and Systemic Diseases (2012)</p></li>
<li><p>V National Update Meeting in Autoimmune and Systemic Diseases for Residents of the La Paz University Hospital (2011)</p></li>
<li><p>XXXII National Congress of the Spanish Society of Internal Medicine (SEMI) and XIV Congress of the Canarian Society of Internal Medicine (2011)</p></li>
<li><p>XV National Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology (2011)</p></li>
<li><p>Course of Advanced Life Support for Adults of the Catalan Resuscitation Council/European Resuscitation Council (Barcelona 2011)</p></li>
<li><p>XIV Congress of the Catalano-Balearic Internal Medicine Society (2011)</p></li>
<li><p>5th Update on Autoimmune Diseases (Barcelona 2010)</p></li>
<li><p>XXII Congress of the Endocrinology and Nutrition Society of Valencia (2010)</p></li>
<li><p>La Paz University Hospital (2010)</p></li>
<li><p>II Update Workshop in Systemic and Autoimmune Diseases of the</p></li>
<li><p>VI Update on Infectious Diseases of the La Paz University Hospital (2010)</p></li>
<li><p>XCII Course of Digestive Pathology of the Santa Creu and San Pau Hospital (2009)</p></li>
<li><p>SAP navigation (2009)</p></li>
<li><p>Hospitalization SAP course for physicians (2009)</p></li>
<li><p>Emergency SAP course for physicians (2009)</p></li>
<li><p>Ambulatory SAP course for physicians (2009)</p></li>
<li><p>Immersion program of the Vall d’Hebron University Hospital (2009)</p></li>
<li><p>III Congress of the Spanish Society of Pharmacogenetics and Pharmacogenomics (2007)</p></li>
<li><p>I Iberian Congress of Medical Students (CARES 2007).</p></li>
<li><p>Course of Introduction to Research in Biochemistry and Molecular Biology of the Spanish Society of Biochemistry and Molecular Biology (SEBBM) and Department of Biochemistry and Molecular Biology, University of Málaga</p></li>
<li><p>XXX Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM)</p></li>
<li><p>Applications of Magnetic Resonance to Biomedical Sciences. Rede de Infraestructuras de Apoio á Investigación e ó Desenvolvemento Tecnolóxico (RIADT) 2007</p></li>
<li><p>Confocal Microscopy Course and its Applications. Rede de Infraestructuras de Apoio á Investigación e ó Desenvolvemento Tecnolóxico (RIADT) 2007</p></li>
<li><p>XII Congress of Cardiology for Students (CARES 2006)</p></li>
<li><p>XI Congress of Cardiology for Students (CARES 2005)</p></li>
</ol>
</section>
<section id="scholarships-grants-and-awards" class="level1">
<h1>SCHOLARSHIPS, GRANTS, AND AWARDS:</h1>
<ol type="1">
<li><p>2023 NIAMS Director’s Group Award as part of the NIAMS Myositis Group</p></li>
<li><p>2022 NIAMS Director’s Group Award as part of the COVID-19 Systemic Autoimmunity Team</p></li>
<li><p>The Mosaic of Autoimmunity Award 2022</p></li>
<li><p>Fellowship to attend the 2019 Global Conference on Myositis meeting</p></li>
<li><p>Extraordinary doctorate award of the Open University of Barcelona 2020</p></li>
<li><p>Award for the best poster: Myositis autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients. NIAMS IRP Scientific Retreat 2017</p></li>
<li><p>Travel bursary for EULAR Congress (2014, 2017)</p></li>
<li><p>Best Young Internist Award of the Spanish Society of Internal Medicine (SEMI) 2016</p></li>
<li><p>Myositis Association Fellowship Award 2016</p></li>
<li><p>Extraordinary doctorate award of the Autonomous University of Barcelona 2016</p></li>
<li><p>Award for the best oral communication: Statin-associated autoimmune myopathy: description of a characteristic immunofluorescent pattern and its correlation with anti-HMGCR autoantibodies. XVI Congress of the Catalano-Balear Society of Internal Medicine 2016</p></li>
<li><p>Award for the best oral communication: Update of the IgG4 Spanish registry after one year and a half. National Congress of the Spanish Society of Internal Medicine (SEMI) 2015</p></li>
<li><p>Rio Hortega Postdoctoral Fellowship Award from the Spanish Ministry of Economy and Competitiveness (2015).</p></li>
<li><p>Joan Vivancos award for the best article published during 2014 (“Pregnancy in adult-onset idiopathic inflammatory myopathy: Report from a cohort of myositis patients from a single center”). Academy of Medical Sciences of Catalonia and the Balearic Islands and the Catalonian-Balearic Society of Internal Medicine.</p></li>
<li><p>Grant to attend the VI School of Internal Medicine for residents 2014.</p></li>
<li><p>Grant to attend the Seminar of Clinical Research of the European Federation of Internal Medicine 2013</p></li>
<li><p>Grant to attend the 3rd European School of Internal Medicine 2013</p></li>
<li><p>CTO Award 2011 for the best research project conducted by a hospital resident</p></li>
<li><p>Postgraduate Research Fellowship Award of Xunta de Galicia (2008-2009)</p></li>
<li><p>Scholarship of the Ministry of Education and Science for the Collaboration with the Department of Medicine (2007/2008)</p></li>
<li><p>CTO Award 2007 for the best complementary development to the medical education for medical students</p></li>
<li><p>Award for the best oral communication: NMR Determination of fat content in the thymus of C57BL / 6. Analysis of its variation with age. I Iberian Congress of Medical Students (CibeMe 2007)</p></li>
<li><p>Conferences, symposia, and seminars grant for university students. Xunta de Galicia (2006)</p></li>
<li><p>Award for the best oral communication: Predictors of Sudden Death and Heart Failure in Patients with Refractory Heart Failure. XII Cardiology Students Congress (CARES 2006)</p></li>
</ol>
</section>
<section id="research-protocols" class="level1">
<h1>RESEARCH PROTOCOLS:</h1>
<ol type="1">
<li><p>000894-AR: Natural History of Inflammatory Muscle Diseases Associate Investigator NIAMS/NIH Bethesda, United States of America 2023-Present</p></li>
<li><p>01-AR-0227 (NCT00024479): Studies of the Natural History of Rheumatic Disease in Minority Communities. Associate Investigator NIAMS/NIH Bethesda, United States of America 2022-Present</p></li>
<li><p>000207-AR (NCT04690816): The Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases; An Observational Prospective Study. Associate Investigator NIAMS/NIH Bethesda, United States of America 2022-Present</p></li>
<li><p>91-AR-0196 (NCT00001265): Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis and Related Diseases.<br>
Associate Investigator NIAMS/NIH Bethesda, United States of America 2018-2024</p></li>
<li><p>NIH study RA101495-02.202 (NCT04025632): Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy. Associate Investigator NIAMS/NIH Bethesda, United States of America<br>
2019-2020</p></li>
<li><p>NIH study 04-C-0281 (NCT00092235): Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease. Collaborator NIAMS/NIH Bethesda, United States of America 2019-Present</p></li>
<li><p>NIH study MSB0010718C (NCT01772004): Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor). Collaborator NIAMS/NIH Bethesda, United States of America 2019-Present</p></li>
<li><p>Hopkins study NA_00007454: Development of a Research Database of Myositis Patients.<br>
Co-Investigator Johns Hopkins University Baltimore, United States of America 2013-Present</p></li>
<li><p>Hopkins study IRB00235256: Myositis Research Registry. Co-Investigator Johns Hopkins University Baltimore, United States of America 2020-Present</p></li>
<li><p>Hopkins study IRB00075085: Development of a questionnaire database for Myositis Patients. Co-Investigator Johns Hopkins University Baltimore, United States of America 2015-2020</p></li>
<li><p>Hopkins study IRB00169980: The Link Between Nailbed Capillaroscopy and Cerebrovascular Disease. Co-Investigator Johns Hopkins University Baltimore, United States of America 2018-2019</p></li>
<li><p>Hopkins study NA_00018091: Neuromuscular Clinic Patient Registry.<br>
Co-Investigator Johns Hopkins University Baltimore, United States of America 2015-2020</p></li>
<li><p>Hopkins study NA_00034985: Clinical Epidemiology of Lung Disease and Other Features of Scleroderma and Other Connective Tissue Diseases. Co-Investigator Johns Hopkins University Baltimore, United States of America 2016-Present</p></li>
<li><p>Hopkins study NA_00081989 A single center experience of using rituximab for treatment of granulomatosis with polyangiitis and microscopic polyangiitis. Co-Investigator Johns Hopkins University Baltimore, United States of America 2013</p></li>
<li><p>FIS grant (PI18/01609): Tumor-infiltrating lymphocytes and cancer-associated dermatomyositis.<br>
Collaborator Vall d’Hebron Hospital Barcelona-Spain 2018-Present</p></li>
<li><p>FIS grant (PI15/02100): Identification of new antigens in patients with inflammatory myopathy. Co-Investigator Vall d’Hebron Hospital Barcelona-Spain 2015-2018</p></li>
</ol>
</section>
<section id="peer-review-activities" class="level1">
<h1>PEER-REVIEW ACTIVITIES:</h1>
<ul>
<li><p>Assistant Editor for Frontiers in Immunology (2022-2024)</p></li>
<li><p>Review Editor for Frontiers in Immunology (2021-2022)</p></li>
<li><p>Section Editor for Current Treatment Options in Rheumatology (2020-2022)</p></li>
<li><p>Reviewer for Cancer Research UK grant applications</p></li>
<li><p>Reviewer for journals:</p>
<ul>
<li>ACR meeting 2020 (Myositis/Myopathies Abstract Review Committee)</li>
<li>Acta Dermato-Venereologica</li>
<li>Annals of Internal Medicine</li>
<li>Annals of the Rheumatic Diseases</li>
<li>Archivos de Medicina</li>
<li>Arthritis &amp; Rheumatology</li>
<li>Arthritis Care &amp; Research</li>
<li>BMC Rheumatology</li>
<li>BMJ Case Reports</li>
<li>European Journal of Neurology</li>
<li>European Radiology</li>
<li>Experimental Neurology</li>
<li>Frontiers in Immunology</li>
<li>Frontiers in Genetics of Common and Rare Diseases</li>
<li>Journal of Clinical Laboratory Analysis</li>
<li>Journal of Musculoskeletal Pain</li>
<li>Journal of Rheumatology</li>
<li>Journal of Thoracic Disease</li>
<li>Journal of the Neurological Sciences</li>
<li>Journal of Neuromuscular Diseases</li>
<li>Lancet</li>
<li>Life Sciences</li>
<li>Medical Science Monitor</li>
<li>Medicina Clínica</li>
<li>Muscle and Nerve</li>
<li>Neuroimmunology and Neuroinflammation</li>
<li>Neurology</li>
<li>Neuropathology and Applied Neurobiology</li>
<li>Neuromuscular Disorders</li>
<li>Oxford Medical Case Reports</li>
<li>RMD Open Rheumatic &amp; Musculoskeletal Diseases</li>
<li>Rheumatology</li>
<li>Rheumatology and Therapy</li>
<li>Scandinavian Journal of Immunology</li>
<li>Seminars in Arthritis and Rheumatism</li>
</ul></li>
</ul>
</section>
<section id="collaboration-with-pharmaceutical-companies" class="level1">
<h1>COLLABORATION WITH PHARMACEUTICAL COMPANIES:</h1>
<ul>
<li>Otsuka Pharmaceutical advisory consultant (2012)</li>
</ul>
</section>
<section id="membership-in-scientific-associations" class="level1">
<h1>MEMBERSHIP IN SCIENTIFIC ASSOCIATIONS:</h1>
<ul>
<li><p>Member of the Scientific Committee for the Journée Interdisciplinaire du Muscle Inflammatoire (JIMI) (from 2024)</p></li>
<li><p>Cutaneous Chronic GVHD Task Force Planning Meeting (2024)</p></li>
<li><p>Member of the International Myositis Assessment and Clinical Studies Group Scientific Committee (2019-2020, 2023-Present)</p></li>
<li><p>Myositis Assessment and Clinical Studies Group (from 2019)</p></li>
<li><p>American College of Rheumatology (from 2018)</p></li>
<li><p>European Society of Internal Medicine (from 2010)</p></li>
<li><p>Health and Medical Sciences Academy of Catalonia and the Balearic Islands (from 2010)</p></li>
<li><p>Spanish Society of Internal Medicine (from 2010)</p></li>
<li><p>Catalonian-Balearic Society of Internal Medicine (from 2010)</p></li>
</ul>
</section>
<section id="languages" class="level1">
<h1>LANGUAGES:</h1>
<table class="caption-top table">
<colgroup>
<col style="width: 24%">
<col style="width: 24%">
<col style="width: 24%">
<col style="width: 24%">
</colgroup>
<thead>
<tr class="header">
<th></th>
<th style="text-align: left;"><strong>Speech</strong></th>
<th style="text-align: left;"><strong>Reading</strong></th>
<th style="text-align: left;"><strong>Writing</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>English</strong></td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
</tr>
<tr class="even">
<td><strong>Spanish</strong></td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
</tr>
<tr class="odd">
<td><strong>Galician</strong></td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
<td style="text-align: left;">Good</td>
</tr>
</tbody>
</table>


</section>

<a onclick="window.scrollTo(0, 0); return false;" role="button" id="quarto-back-to-top"><i class="bi bi-arrow-up"></i> Back to top</a></main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleGiscusIfUsed = (isAlternate, darkModeDefault) => {
    const baseTheme = document.querySelector('#giscus-base-theme')?.value ?? 'light';
    const alternateTheme = document.querySelector('#giscus-alt-theme')?.value ?? 'dark';
    let newTheme = '';
    if(darkModeDefault) {
      newTheme = isAlternate ? baseTheme : alternateTheme;
    } else {
      newTheme = isAlternate ? alternateTheme : baseTheme;
    }
    const changeGiscusTheme = () => {
      // From: https://github.com/giscus/giscus/issues/336
      const sendMessage = (message) => {
        const iframe = document.querySelector('iframe.giscus-frame');
        if (!iframe) return;
        iframe.contentWindow.postMessage({ giscus: message }, 'https://giscus.app');
      }
      sendMessage({
        setConfig: {
          theme: newTheme
        }
      });
    }
    const isGiscussLoaded = window.document.querySelector('iframe.giscus-frame') !== null;
    if (isGiscussLoaded) {
      changeGiscusTheme();
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
    // Hack to workaround the fact that safari doesn't
    // properly recolor the scrollbar when toggling (#1455)
    if (navigator.userAgent.indexOf('Safari') > 0 && navigator.userAgent.indexOf('Chrome') == -1) {
      manageTransitions("body", false);
      window.scrollTo(0, 1);
      setTimeout(() => {
        window.scrollTo(0, 0);
        manageTransitions("body", true);
      }, 40);  
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  const darkModeDefault = false;
  let localAlternateSentinel = darkModeDefault ? 'alternate' : 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
    toggleGiscusIfUsed(toAlternate, darkModeDefault);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } else {
    toggleColorMode(false);
  }
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const onCopySuccess = function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  }
  const getTextToCopy = function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
    text: getTextToCopy
  });
  clipboard.on('success', onCopySuccess);
  if (window.document.getElementById('quarto-embedded-source-code-modal')) {
    // For code content inside modals, clipBoardJS needs to be initialized with a container option
    // TODO: Check when it could be a function (https://github.com/zenorocha/clipboard.js/issues/860)
    const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
      text: getTextToCopy,
      container: window.document.getElementById('quarto-embedded-source-code-modal')
    });
    clipboardModal.on('success', onCopySuccess);
  }
    var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
    var mailtoRegex = new RegExp(/^mailto:/);
      var filterRegex = new RegExp('/' + window.location.host + '/');
    var isInternal = (href) => {
        return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
    }
    // Inspect non-navigation links and adorn them if external
 	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
    for (var i=0; i<links.length; i++) {
      const link = links[i];
      if (!isInternal(link.href)) {
        // undo the damage that might have been done by quarto-nav.js in the case of
        // links that we want to consider external
        if (link.dataset.originalHref !== undefined) {
          link.href = link.dataset.originalHref;
        }
      }
    }
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      if (note) {
        return note.innerHTML;
      } else {
        return "";
      }
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->




</body></html>